X @Bloomberg
Bloomberg·2026-07-09 02:48
Biotech dealmaking has hit a “torrid pace” in 2026, with more transactions exceeding $1 billion already completed this year than in all of 2025 combined, says Krishna Veeraraghavan, co-head of global M&A at Paul Weiss https://t.co/E8D4RkJaXC ...